Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: Results of the AFR04 study
Hemoglobin decline, function, and mortality in the elderly: The cardiovascular health study
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia
Patients with sickle cell disease have increased sensitivity to cold and heat
Changes in the properties of normal human red blood cells during in vivo aging
Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: Results of multicenter analysis
FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
Patterns of survival in lymphoplasmacytic lymphoma/waldenström macroglobulinemia: A population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005
Missense mutations in the ABCB6 transporter cause dominant familialpseudohyperkalemia
Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management
“Flatland: A romance of many dimensions”
A unifying diagnosis for pancytopenia, fever, hypoglycemia, and lactic acidosis
The isolated prolonged PTT
Polyclonal B lymphocytosis with binucleated lymphocytes in a man
Progression of double-hit lymphoma in the midst of R-hyper CVAD
The American Journal of Hematology would like to thank the colleagues who have spent an enormous amount of time and energy reading and critiquing submitted manuscripts. Below we list those who have served as ad hoc reviewers for the journal in 2011 and 2012.